Skip to content
10-K

Annual Report

YIELD10 BIOSCIENCE, INC.

0001121702-24-000021

← back to feed
Filed
Apr 1, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 28, 2024 15.4M sh
Shares Diluted FY 2023 · Dec 31, 2023 7.95M sh
Shares Diluted FY 2023 · Dec 31, 2022 4.91M sh
Capex FY 2023 · Dec 31, 2023 $46K
Capex FY 2023 · Dec 31, 2022 $154K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$10.07M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$11.4M
Short Term Investments FY 2023 · Dec 31, 2023 $0
Short Term Investments FY 2023 · Dec 31, 2022 $1.99M
Cash And Equivalents FY 2023 · Dec 31, 2023 $1.07M
Cash And Equivalents FY 2023 · Dec 31, 2022 $2.36M
Stockholders Equity FY 2023 · Dec 31, 2023 −$2.48M
Stockholders Equity FY 2023 · Dec 31, 2022 $4.4M
Stockholders Equity FY 2023 · Dec 31, 2021 $16.03M
Current Liabilities FY 2023 · Dec 31, 2023 $4.87M
Current Liabilities FY 2023 · Dec 31, 2022 $1.61M
Total Liabilities FY 2023 · Dec 31, 2023 $6.39M
Total Liabilities FY 2023 · Dec 31, 2022 $3.69M
Current Assets FY 2023 · Dec 31, 2023 $1.4M
Current Assets FY 2023 · Dec 31, 2022 $5.02M
Total Assets FY 2023 · Dec 31, 2023 $3.91M
Total Assets FY 2023 · Dec 31, 2022 $8.09M
Eps Diluted FY 2023 · Dec 31, 2023 −$1.82
Eps Diluted FY 2023 · Dec 31, 2022 −$2.76
Eps Basic FY 2023 · Dec 31, 2023 −$1.82
Eps Basic FY 2023 · Dec 31, 2022 −$2.76
Sga Expense FY 2023 · Dec 31, 2023 $6.15M
Sga Expense FY 2023 · Dec 31, 2022 $6.15M
Net Income FY 2023 · Dec 31, 2023 −$14.46M
Net Income FY 2023 · Dec 31, 2022 −$13.57M
Operating Income FY 2023 · Dec 31, 2023 −$14.42M
Operating Income FY 2023 · Dec 31, 2022 −$13.45M
Revenue FY 2023 · Dec 31, 2023 $60K
Revenue FY 2023 · Dec 31, 2022 $450K